Piper Jaffray - David Amsellem
Stifel Nicolaus - Thomas Shrader
H.C. Wainwright & Co. - Andrew Fein
LifeSci Capital - Jerry Isaacson, Ph.D.
Windtree Therapeutics is followed by the analyst listed above. Please note that any opinions, estimates or forecasts regarding Windtree Therapeutics' performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Windtree Therapeutics or its management. Windtree Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
This website may link you to other websites that are not owned or controlled by Windtree Therapeutics. These links are provided for your convenience only. These sites are maintained by entities over which Windtree Therapeutics exercises no control. Accordingly, Windtree Therapeutics expressly disclaims any responsibility for the content, the accuracy of the information and/or quality of products or services provided by or advertised on these third-party sites. If you choose to hyperlink to another website, you do so at your own risk.